Qualigen Therapeutics (Ritter Pharmaceuticals) ^{Priced, Nasdaq: QLGN}

Developing an oral therapy that reduces the symptoms of lactose intolerance.

Industry: Health Care

First Day Return: -0.8%

Industry: Health Care

QLGN

Developing an oral therapy that reduces the symptoms of lactose intolerance.

more less

IPO News for Qualigen Therapeutics (Ritter Pharmaceuticals)

Ritter Pharmaceuticals prices IPO at downwardly revised price of $5; now has $39 million market cap 06/24/15
Week ahead: As many as 17 IPOs could price during the week of June 22 06/22/15
Ritter Pharmaceuticals drops proposed IPO price; market cap down 45% to $39 million 06/19/15

IPO Data
IPO File Date	03/23/2015
Offer Price	$5.00
Price Range $5.00 - $5.00
Offer Shares (mm)	4.0
Deal Size ($mm)	$20
Lock-Up Date	IPO Pro Only
Street Research	IPO Pro Only

IPO Data
IPO Date	06/23/2015
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$20
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Headquarters	Los Angeles, CA, United States
Founded	2004
Employees at IPO	5
Website www.ritterpharmaceuticals.com

IPO News for Qualigen Therapeutics (Ritter Pharmaceuticals)

Qualigen Therapeutics (Ritter Pharmaceuticals) (QLGN) Performance